Preimplantation Genetic Testing - Aneuploidy

Overview

Preimplantation Genetic Testing for Aneuploidy (PGT-A) assesses the number of chromosomes in each of your patient’s IVF embryos to identify any embryos that may be chromosomally abnormal (this is also often called preimplantation genetic screening, or PGS). By purposefully selecting chromosomally normal embryos for implantation, you can greatly expand your patient’s prospects of a successful IVF treatment and a healthy pregnancy.

Track your orders easily through the Eve Provider Portal, which also includes an intuitive, customizable dashboard and access to order forms and status updates.
Rest assured knowing that our dedicated customer support team and genetic counselors are available to answer any questions or concerns.
Receive useful, easy-to-read reports.

Order Now >

Ordering and Shipping Details

Order specimen kits. Kits will include the following:
- Test requisition form (TRF)
- Embryo biopsy worksheet
- Sample tubes/rack
- Buffer solution
- Ice packs
- Prepaid shipping label
Collect biopsy sample and ensure samples are appropriately labeled.
- All orders must include a TRF and embryo biopsy worksheet.
Ship frozen biopsy samples for overnight delivery using the provided kits and return label.

Contact us at [email protected] for any questions.

Turnaround Time

1-2 weeks

Sample Requirements

Blastocyst/Trophectoderm biopsy

Sample Report

Email us to view a sample report.

Limitations: The purpose of this test is limited to the detection of aneuploidy (differences in whole chromosome copy number) within in vitro fertilized embryos for the purpose of embryo selection. This test does not: screen for other genetic conditions (single gene disorders), detect all potential birth defects, or guarantee a successful pregnancy outcome. Additional risk factors affecting a pregnancy can occur for genetic and/or non-genetic reasons. Submicroscopic deletions and duplications are generally not detected or reported. Due to technological and specimen limitations, some risk for aneuploidy remains even if this test is negative. Undergoing a confirmatory invasive prenatal diagnostic procedure - chorionic villus sampling (CVS) or amniocentesis - is highly recommended regardless of the outcome of this test. This test is not able to detect balanced translocations. This test is not considered routine medical care. This is not able to detect balanced translocations (structural chromosome rearrangements), all partial aneuploidy (partial deletions/duplications of chromosomes), all cases of mosaicism, and/or all forms of polyploidy (deletions/duplications of chromosome sets).